GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Eif4b | decreases phosphorylation | EXP | | 6480464 | CTD | resveratrol results in decreased phosphorylation of EIF4B protein | PMID:24304514 | Eif4b | multiple interactions | EXP | | 6480464 | CTD | [Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein | PMID:24304514 | Eif4b | decreases expression | ISO | Eif4b (Mus musculus) | 6480464 | CTD | resveratrol results in decreased expression of EIF4B protein | PMID:25505154 | Eif4b | decreases phosphorylation | ISO | EIF4B (Homo sapiens) | 6480464 | CTD | resveratrol results in decreased phosphorylation of EIF4B protein | PMID:25311616 | Eif4b | decreases phosphorylation | ISO | Eif4b (Mus musculus) | 6480464 | CTD | resveratrol results in decreased phosphorylation of EIF4B protein | PMID:24304514 | Eif4b | multiple interactions | ISO | EIF4B (Homo sapiens) | 6480464 | CTD | [resveratrol co-treated with Sirolimus] results in decreased phosphorylation of EIF4B protein | PMID:24304514 | Eif4b | multiple interactions | ISO | Eif4b (Mus musculus) | 6480464 | CTD | [resveratrol co-treated with Sirolimus] inhibits the reaction [TSC2 gene mutant form results in increased phosphorylation of EIF4B protein]; [Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein | PMID:24304514 | |
Go Back to source page | Continue to Ontology report |